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Abstract 
Background/Aim: There is an unsatisfied clinical demand to develop new anticancer agents. The aim of the 
current study was to synthesize new coumarin derivatives using two different synthetic methodologies and to 
evaluate their anticancer activity. Materials and methods: Four coumarin derivatives were synthesized and 
evaluated for their anticancer activities. The structures of all compounds were confirmed by infrared (IR), UV-
vis, Nuclear magnetic resonance (NMR) 13C NMR, 1H NMR, and high-resolution mass spectrometry (HRMS) 
analysis.  
------------------------------------------------------------------------ 
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All the synthesized compounds (4, 5, 8 and 9) were analyzed for their anti-proliferative (MTT and LDH assays 
and cell cycle studied with flow cytometry) and anti-invasive activity (spreading and invasion tests) on human 
hepatoma cell lines Huh-7 in vitro. Doxorubicin was used as control in order to compare their anti-tumoral 
effects. Results. All the synthesized compounds are potential inhibitors of proliferation, viability, spreading and 
invasion of human liver tumor cells with a 50% inhibitory Concentration range,  IC50=10.37 μM to 12.94 μM. 
Conclusion. This study could lead to the identification of a new target therapy for human Hepatocellular 
carcinoma (HCC) or other cancers.  
Keywords: Fraud pentagon; fraudulent financial reporting; non-financial company. 
1. Introduction 
Coumarins, natural or synthetic, have become an interesting subject of investigation for many researchers due to 
their biological properties and characteristics and conjugated molecular architecture. Coumarins have proven to 
have an interesting role in anticancer drug development since many of their derivatives have shown an 
antitumor activity on various cell lines [1]. Research conducted on these coumarins and their metabolites 
showed promising activity against several types of cancer such as lung, malignant melanoma, prostate, breast, 
leukemia, and hepatocellular carcinoma. Anticancer activity of coumarin derivatives has been previously shown 
[1, 2, 3, 4, 5, 6, 7] and it has been shown that coumarins can act on various cancer cells by different 
mechanisms; they inhibit the protein kinase telomerase enzyme activity, down regulate oncogene expression or 
induce the caspase-9-mediated apoptosis, suppress tumor cell proliferation by arresting cell cycle in G0/G1 or 
G2/M phase in cancer cells [8, 9]. Some researches proved that 7-hydroxycoumarin can inhibit growth of human 
cancer cell lines [10], such as A549 (lung), ACHN (renal), H727 (lung), MCF7 (breast) and HL-60 (leukaemia) 
and in some clinical trials they exhibited anti-proliferative activity in prostate cancer [11], renal carcinoma [12] 
and malignant melanoma [13]. 
The invasion is one of the most important prerequisite for cancer progression and metastasis because the growth 
of the primary tumor is dependent on its invasive potential within the host tissue. For this reason the 
development of new coumarin derivatives able to inhibit tumor invasion is a logical continuation of the research 
of new anticancer products. 
Knowing that cancer cells, including Human hepatoma cells Huh7, are capable of degrading the constituents of 
the extracellular matrix (ECM), and the basement membrane which is a highly cross-linked network composed 
mainly of type IV collagen, laminin and heparan sulfate-based proteoglycans [14]. 
This proteolysis involves enzymes secreted by the cancer cells and by stromal cells (fibroblasts) stimulated by 
soluble factors secreted by the cancer cells. These enzymes are in particular matrix metalloproteases. In 
addition, the process also involves a break in the equilibrium between these enzymes and their inhibitors and the 
chemiokines, which are involved in cancer progression. Chemokines, chemotactic cytokines, like Regulated 
upon Activation, Normal T cell Expressed, and Secreted (RANTES/CCL5) and monocyte chemoattractant 
protein-1 (MCP-1)/CCL2, play an important role in tumor biology because they may inﬂuence cell growth, 
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angiogenesis, invasion and metastasis [15, 16, 17]. 
It has been previously shown that 4-hydroxycoumarin follow different pathways such as aromatase and 
sulphatase inhibition, cell cycle arrest and cell apoptosis induction [14]. However, coumarin itself also exhibited 
a cytotoxic effect against human epithelial cells which showed some typical characteristics of apoptosis with 
loss of membrane microvilli and nuclear DNA fragmentation. These anticancer properties cited above 
encouraged us to synthesize a novel series of 4-substituted-4-hydroxycoumarin derivatives (HCD) obtained with 
two different synthesis processes from 4-hydroxycoumarin. 
Each process was performed in three steps and led to two regioisomers. The first process has been already 
reported in the literature for the preparation of 1-phenyl [1]benzopyrano[4,3-c]pyrazol-4(2H)-one (4) and 1-
Benzyl [1]benzopyrano[4,3-c]pyrazol-4(2H)-one (5) [18], while the second one was realized for the first time in 
our team and led to the 2-phenyl[1]benzopyrano[4,3-c]pyrazol-4(2H)-one (8) and the 2-
Benzyl[1]benzopyrano[4,3-c]pyrazol-4(2H)-one (9). These processes were chosen for their selective properties 
leading to the targeted regioisomers. The aim of our work was to synthesize the new 4-hydroxycoumarin 
derivatives, determine whether these new coumarin derivatives have anticancer effect and are involved in 
inhibition of hepatocellular carcinoma cells Huh7 proliferation, spreading, cell cycle and invasion. 
2. Materials and methods 
2.1. Reagents and materials 
The starting materials 6 and 7 were prepared according to the literature [19, 20]. All reactions were followed by 
TLC using aluminum sheets of Merck silica gel 60 F254, 0.2 mm and plates were revealed using a UV 254 
light. Melting points were taken on a Buchi-510 capillary apparatus and are uncorrected. 
1H, 13C and two-dimensional NMR spectra were recorded with AC-400 Bruker spectrometer at room 
temperature (rt) in CDCl3or DMSO d-6 at 400 MHz and at 100 MHz, using residual non deuterated solvent 
peaks as internal reference. Coupling constants are given in Hz. IR spectra were recorded on a Perkin Elmer 
Spectrum two FT-IR instrument with the Universal ATR Sampling Accessory. The HRMS spectra were 
acquired with an electrospray- time-of-flight (ESI-TOF, LCT Premier XE, and Waters) mass spectrometer in the 
positive ion mode.  
2.2. General procedure for the preparation of 4-chloro-2-oxo-2H chromene-3-carbaldehyde (2) 
To a stirred mixture of 4-hydroxycoumarin (2.2 g) in anhydrous DMF (15 ml) were added drop wise POCl3 (15 
ml) at -10 to -5°C. The reaction mixture was then stirred for 1 h at room temperature, heated, and stirred for 12 
h at 60°C. After the reaction was completed, the mixture was poured onto crushed ice (100 g) under vigorous 
stirring. After storing the mixture overnight at 0°C, the pale yellow solid was collected by filtration and washed 
successively with aqueous Na2CO3 (5%) and water, and then was air-dried. 
Recrystallization from acetone gave 1.7 g (65%) of 2 as a pale yellow powder with mp 115–120 °C. IR (ATR, 
νmaxcm-1): 2920, 2874, 1720, 1702, 1603, 1587, 1541 cm‾¹; 1H NMR (400 MHz, CDCl3) δH : 10.39 (1H, s, 
International Journal of Sciences: Basic and Applied Research (IJSBAR) (2019) Volume 42, No  5, pp 167-185 
 
170 
 
CH=O), 8.19–7.40 (4H, m, Ar-H); 13C NMR (100 MHz, CDCl3) δC : 186.81, 158.44, 153.28, 153.27,135.68, 
127.65, 125.56, 118.39, 118.22, 117.20.  
2.3. Synthesis of (E)-4-chloro-3-(2-phenylhydrazono)-2H-chromen-2-one (3a) 
A mixture of phenylhydrazine hydrochloride (0.160 g,1.1 mmol) and triethylamine (2.2 mmol) in(10 ml)of 
ethanol was slowly added drop wise to a stirred solution of 4-chloro-2-oxo-2H-chromene-3-carbaldehyde  
(0.208 g,1.0 mmol) in (10 ml) ethanol at 60°C and the reaction was continued for another 15 min at same 
temperature. The reaction was monitored by TLC and an orange-red precipitate formation was observed. The 
reaction mixture was cooled to room temperature; precipitate was rapidly filtered off and then washed with cold 
water to afford (E)-4-chloro-3-((2-phenylhydrazono) methyl)-2H-chromen-2-one (3a) (0.275 g) as orange red 
color solid in 92% yield. M.p: 181-183°C;IR (ATR, νmaxcm-1): 3284, 2921,2851, 1696, 1596, 1521, 1488, 1447, 
1280, 1253, 1084 cm‾¹;1H NMR (400 MHz, DMSO-d6)δH: 11.11 (bs, 1H, NH), 8.16 (s, 1H, =CHimine), 8.04 (d, 
1H,J = 8 Hz, aromatic), 7.75 (t, 1H, J = 8 Hz, aromatic), 7.56 (t, 2H, J = 4 Hz,aromatic), 7.36 (t, 2H, J = 8 Hz, 
aromatic), 7.20 (d, 2H, J = 8 Hz, aromatic), 6.93 (t, 1H, J = 4 Hz,aromatic).13C NMR (100 MHz, DMSO-d6) δC: 
158.7, 150.7, 144.8, 139.5, 132.6, 129.9, 129.7, 125.7, 125.6, 120.5, 120.2, 119.4, 116.8, 112.9. HRMS (ESI-
TOF) for C16H11ClN2O2 [M + H]+: calcd, 299.0511 found 299.3011. 
2.4. Synthesis of (E)-4-chloro-3-(2-benzylhydrazono)-2H-chromen-2-one (3b) 
Benzylhydrazine dihydrochloride  (0.422 g, 2.2 mmol) in mixture of H2O and AcOH was added to a stirred 
solution of 4-chloro-2-oxo-2H-chromene-3-carbaldehyde 2 (0.416 g, 2.0 mmol) in methanol at 60 °C and the 
reaction was continued for another 30 min at same temperature.  
The reaction was monitored by TLC and an orange precipitate formation was observed. After completion of the 
reaction, the reaction mixture was cooled to room temperature, precipitate was filtered off, and the resulted 
precipitate was dissolved in ethyl acetate and washed with cold water to remove acetic acid. The organic layer 
was separated and dried over Na2SO4, solvent was removed under reduced pressure afforded (E)-4-chloro-3-((2- 
benzylhydrazono) methyl)-2H-chromen-2-one (3b) (0.522 g) as orange color solid in 85% yield. M.p: 195-
198°C;1H NMR (400 MHz, CDCl3)δH: 11.11 (bs, 1H, NH), 8.16 (s, 1H, =CHimine), 8.04 (t, 1H,J = 4 Hz, 
aromatic), 7.33-7.38 (m, 4H, aromatic), 7.21-7.25 (m, 2H, aromatic), 4.19 (s, 2H, CH2).13C NMR (100 MHz, 
CDCl3) δC: 156.3, 151.8, 139.8, 138.0, 133.9, 130.0, 128.2, 127.2, 125.1, 123.4, 121.5, 117.3, 110.4, 107.7, 
54.7.HRMS (ESI-TOF) for C17H13ClN2O2 [M + H]+: calcd, 313.0666 found 313.0671. 
2.5. General procedure of the preparation of 1-phenylchromeno[4, 3-c]pyrazol-4(1H)-one (4) and  1-
benzylchromeno[4,3-c]pyrazol-4(1H)-one (5) 
Catalytic amount of piperidine was added to a stirred solution of4-chloro-3-(N-substituted hydrazino)-2H-
chromen-2-ones (1mmol) in pyridine (5mL), and contents were refluxed for 2 h. After completion of the 
reaction indicated by TLC and the formation of a dark red color, reaction mixture was cooled to room 
temperature and diluted with water (3 mL). 
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Dilute chlorhydric acid was added to the crude mixture, to quench the excess of pyridine. The brown precipitate 
so-formed was filtered, washed with water and purified over silica gel (60-120) afforded compounds 4-5 as pale 
yellow color solids in 78-85% yield. 
2.6. Preparation of 1-phenylchromeno [4, 3-c]pyrazol-4(1H)-one (4) 
Yield: 78%,yellow color solid, mp = 192°C; IR(ATR, νmaxcm-1): 1753, 1535, 981cm‾¹; 1H NMR (400 MHz, 
DMSO-d6)δH: 8.52 (s, 1H, Holefinic), 7.65-7.71 (m,5H, aromatic), 7.53-7.71 (m, 2H, aromatic), 7.20 (t, 1H,J = 8 
Hz, aromatic), 7.00 (d, 1H,J = 8 Hz, aromatic).13C NMR (100 MHz, DMSO-d6) δC:156.9; 152.9, 141.3, 139.9, 
139.5, 132.1, 131.1, 130.5, 127.5, 124.8, 122.5, 118.3, 111.6, 108.3.HRMS (ESI-TOF) for C16H10N2O2 [M + H] 
+: calcd, 263.0741found 263.0741. 
2.7. Preparation of 1-benzylchromeno [4, 3-c] pyrazol-4(1H)-one (5) 
yield:85% ,Yellow color solid, mp = 123°C; IR(ATR, νmaxcm-1):1727,1535, 1022 cm‾¹; 1H NMR (400 MHz, 
DMSO-d6)δH: 8.27 (s, 1H, Holefinic), 7.7 (d, 1H,J = 8 Hz, aromatic),7.49 (t, 1H, J = 8 Hz, aromatic),7.44 (t, 1H,J 
= 8 Hz, aromatic), 7.29-7.36 (m, 3H, aromatic),7.20 (t,1H,J = 8 Hz, aromatic),7.13 (d, 2H,J = 8 Hz, aromatic), 
5.86 (s, 2H, CH2).13C NMR(400 MHz, DMSO-d6)δC: 157.3, 152.8, 140.8, 139.0, 134.9, 131.0, 129.2, 128.3, 
126.1, 124.5, 122.5, 118.3, 111.3, 108.7, 55.8.HRMS (ESI-TOF) for C17H12N2O2 [M + H]+: calcd, 277.0898 
found 277.0905. 
2.8. General procedure of the preparation of 2-phenylchromeno[4,3-c] pyrazol-4(1H)-one (8) and 2-
benzylchromeno[4,3-c]pyrazol-4(1H)-one (9) 
The starting material 1was prepared according to the literature [21] using the two-step formylation/cyclisation 
reaction between 4-(2-hydroxyphenyl)-1, 5-benzodiazepin-2-one and excess of DMFDMA. For the synthesis of 
chromeno-pyrazolone derivatives: (10 mmol) of compound 1 and an excess of phenylhydrazine chlorhydrate or 
benzylhydrazine chlorhydrate (50 mmol) were dissolved in (5 ml) of glacial acetic acid, and refluxed for 2h. The 
reaction mixture was poured into ice and the precipitate filtered then washed successively with water then 
recrystallized from ethanol. 
2.9. Preparation of 2-phenylchromeno [4, 3-c] pyrazol-4(1H)-one (8) 
Yield: 70%, pale yellow color solid, mp = 225°C; IR(ATR, νmaxcm-1): 1733 (C=O),1600( C=N) 1461(C=C 
arom), 1111(C-O-C arom) cm‾¹; 1H NMR (400 MHz, DMSO-d6)δH: 9.61 (s, 1H, Holefinic), 8.07–8.12 (m, 3H, 
aromatic),7.58–7.63 (m, 3H, aromatic), 7.40–7.50 (m, 3H, aromatic), 13C NMR (100 MHz, DMSO-d6)δC: 
157.2, 153.0, 149.2, 139.2, 132.0, 131.5, 130.2, 128.8, 125.3, 123.0, 120.4, 117.8, 114.5, 109.2 .HRMS (ESI-
TOF) for C16H10N2O2 [M + H]+: calcd, 263.0742; found  263.0750. 
2.10. Preparation of 2-benzylchromeno [4, 3-c] pyrazol-4(1H)-one (9) 
Yield: 55%, White cottony, mp =169°C. IR(ATR, νmaxcm-1): 1744 (C=O),1622( C=N) 1464(C=C arom), 
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1089(C-O-C arom) cm‾¹‾; 1H NMR (400 MHz, DMSO-d6)δH: 9.01 (s, 1H, Holefenic), 7.96 (d, 1H,J = 8 Hz, 
aromatic), 7.54 (t, 1H,J = 8 Hz, aromatic), 7.33–7.44 (m, 7H, aromatic), 5.59(s, 2H, CH2).13C NMR (400 MHz, 
DMSO-d6)δC: 157.3, 152.8, 148.8, 136.5, 134.5, 130.9; 129.2; 128.6, 128.4, 125.1, 122.8, 117.7, 114.8, 107.3, 
56.4.HRMS (ESI-TOF) for C17H12N2O2 [M + H] +: calcd, 277.0899 ; found  277.0951. 
2.11. Cell culture and reagents 
 Human hepatoma Huh7 cells were obtained from ATCC (LGC Standards, Molsheim, France). These Cell lines 
were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% Fetal bovine  serum 
(FBS), 2 mM l-glutamine, 1 mM sodium pyruvate, 50 U/ml streptomycin (all obtained from Life Technologies 
Inc.), at 37◦C in a 5% CO2 humidified atmosphere. Cells were subcultivated every 7 days. The medium was 
changed twice a week. All in vitro cell experiments (viability, spreading and invasion assays) were carried out at 
37°C in a 5% CO2 incubator [22]. 
2.12. Cell Viability Assay 
The viability of the cancer cells line Huh7 after treatment by our particles was demonstrated using MTT (3-[4.5-
Dimethylthiazol-2-yl]-2.5-dephenyltetrazolium bromide) assay (Thiazolyl Blue Tetrazolium Bromide, Sigma, 
St. Louis, MO) [23]. 5000 cells/well were seeded in a 96-wells plate for 24, 48 and 72 h with or without the 
different particles at increasing concentration (0.01 µM, 0.1 µM, 1 µM, 10 µM and 100 µM). MTT solution at 1 
mg/mL was added to the medium for 2 h and coloration was revealed in DMSO. The metabolic activity was 
correlated by the absorbance at 570 nm (Bio-rad© Microplate reader, Model 680). Experiments were performed 
in quadruplicate. Dose–response curves were obtained allowing the determination of IC50 values, which refer to 
the concentration inducing a response halfway between the baseline and the maximum plateau reached [24]. 
2.13. Measurement of lactate dehydrogenase (LDH) release  
1. Cellinjurywasalsoquantitatively 
2. assessed by measurement of released lactate dehydrogenase (LDH) 
3. from damaged cells. The LDH assay was performed using the 
4. CytoTOX96 Non-Radioactive CytotoxicityAssay Kit (Promega, 
5. Madison, WI, USA), according to the manufacturer's protocol. 
6. Glutamate-induced LDH release was expressed as a percentage of 
7. experimental LDH release/maximal LDH release which was 
8. induced by treatment of 0.9% Triton X-100. One-way 
9. ANOVA 
10. was 
11. used for the statistical analysis, and signi®cant differences in cell 
12. viability were determined by post hoc comparisons of means using 
13. Bonferroni test 
14. Cellinjurywasalsoquantitatively 
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15. assessed by measurement of released lactate dehydrogenase (LDH) 
16. from damaged cells. The LDH assay was performed using the 
17. CytoTOX96 Non-Radioactive CytotoxicityAssay Kit (Promega, 
18. Madison, WI, USA), according to the manufacturer's protocol. 
19. Glutamate-induced LDH release was expressed as a percentage of 
20. experimental LDH release/maximal LDH release which was 
21. induced by treatment of 0.9% Triton X-100. One-way 
22. ANOVA 
23. was 
24. used for the statistical analysis, and signi®cant differences in cell 
25. viability were determined by post hoc comparisons of means using 
26. Bonferroni test 
27.26. Cell injury was also quantitatively assessed by measurement of released lactate dehydrogenase 
(LDH)from damaged cells.[29] 
The LDH assay was performed using the CytoTOX96 Non-Radioactive Cytotoxicity Assay Kit (Promega, 
Madison, WI, USA), in accordance with the instructions of the manufacturer's protocol. Briefly, after treating 
Huh7 at 90% confluence in 24-well plates with different prodrugs (0.01–100µM) for 24 h, culture medium was 
collected. The induced LDH release was measured as the absorbance at 490 nm using a standard 96-well plate 
reader. Cytotoxicity was expressed relative to basal LDH release in untreated control cells. One-way ANOVA 
was used for the statistical analysis and significant differences in cell viability were determined by post 
comparisons of means [25]. 
Ryota Hashimoto,* Christopher Hough, TakanobuNakazawa,àTadashiYamamotoà 
and De-Maw Chuang* 
2.14. Cell Spreading assay 
Quantitative cell spreading assays were carried out in respective supplemented basal cell culture media. 6500 
cells/well were seeded on the fibronectin (100 µg/mL; Corning)-coated LabTek chambers for 3h at 37C°, 5% 
CO2. Then, the samples were rinsed with PBS then fixed with 150µl of PFA 1% for 20 min at 4C°, and followed 
with 150 µl of Triton 0.05% for 5 min at ambient temperature. Cells were stained subsequently with Alexa Fluor 
546 phalloidin (dilution 1/100, Invitrogen, France) and DAPI (dilution 1/1000, Invitrogen, France) for 1h30 min 
in order to visualize filamentous actin and observed with a fluorescence microscope (Zeiss Axiophot, Carl Zeiss 
France). Cells were photographed using digital camera fixed on top of the microscope (Nikon COOL PIX 8400, 
Japan) and ten fields of stained cells were photographed for each treatment. Cell areas expressed in square 
inches were evaluated on 30 individual cells, measured by Scion Image software (Scion Corporation) [26]. 
Histograms represent mean of cell areas ± SD of three different experiments. 
2.15. Cell Invasion assay 
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Huh7 cell invasion was investigated using Boyden invasion chambers (Becton Dickinson) with 8 mm pore size 
filters coated with Matrigel membrane matrix (100 µg/ml; BD Bioscience PharMingen). 2.5 ×105 Huh7 cells 
with (0.01 µM, 0.1 µM, 1 µM, 10 µM and 100 µM) of each compound (4, 5, 8 and 9) were seeded in the upper 
well of the Boyden chamber. Hepatocyte growth factor (HGF; 20 ng/mL) was used as a positive control [27]. 
After 24 h, non-migrated cells in the upper chamber were wiped with a cotton swab and the cells were fixed in 
methanol and stained with Mayer’s hemalum, and counted. Cells invading the lower surface of the filter were 
counted in 10- fields using a Zeiss microscope. Results were expressed as a percentage relative to controls and 
therefore normalized to 100%. Experiments were performed in triplicate [28]. 
2.16. Flow cytometry analysis 
To analyze the cell cycle of Huh7, 105 cells were seeded into 12- well plates and serum deprived during one 
night. Then, Huh7 were treated or not with the coumarinic derivatives products at 1 or 10 µM during 24h. 
Supernatant and trypsinated cells were then centrifuged during 5 minutes at 1500 rpm. Samples were fixed with 
pre-cooled 75% ethanol for 1h at 4°C. Finally, cells were incubated 15 minutes at room temperature with 10 
µg/mL of propidium iodide (PI)-PBS for flow cytometry analysis. Data were analyzed using FACScalibur 
(Becton Dickinson, CA, USA). 
2.17. Statistical Analysis 
For the determination of statistical significance, an ANOVA test was performed with the Stat view software 
(Stat View 4.5 Abacus Concepts, Berkeley, USA). A p value of <0.05 was used as the criterion for 
statistical significance. 
3. Results 
3.1. Chemistry 
 The coumarin derivatives 4, 5, 8 and 9 were prepared using two general synthetic methods. The regioisomere 4 
and 5 were prepared using the methodology outlined in Figure 3 (Pathway I). 4-Hydroxycoumarin (1) was 
treated with POCl3 and DMF, similarly to standard Vilsmeier-Haack conditions (at -10 to -5°C) [29]. After 
hydrolysis, 4-chloro-3-formylcoumarin (2) was generated. Condensation of 2 with hydrazine hydrochlorides 
derivatives in acidic or basic medium provided the corresponding (E)-4-chloro-3-((2-phenylhydrazono)-2H-
chromen-2-one (3a) and (E)-4-chloro-3-((2-benzylhydrazono)-2H-chromen-2-one (3b) [30].  
The compounds 4 and 5 were obtained by the regioselective cyclisation of their corresponding 2H-
chromenohydrazones 3a and 3b at 100°C with a catalytic amount of piperidine in pyridine in high yields, . 
As shown in Scheme 1(Pathway II), analogues 8 and 9 were prepared using the second methodology. The 
condensation of one equivalent of [1] benzopyrano[4,3-c][1,5]benzodiazepin-7(8H)-one (7) [31] with an excess 
of hydrazine hydrochloride derivatives in boiling acetic acid has given the corresponding products. The starting 
material 7 was prepared according to the literature [32] using the two-step formylation/cyclisation reaction 
between 4-(2-hydroxyphenyl)-1, 5-benzodiazepin-2-one (6) and an excess of dimethylformamide dimethylacetal 
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(DMF-DMA). 
The IR spectra of compound 4 chosen as an illustrative example, has shown absorption bands at 1753, , 1618, 
1535 and 981 cm-1 which corresponded respectively to the stretching vibrations of the (lactone >C=O), (pyrazol 
(C=N), aromatic (C=C), and (C-O-C) bonds 1H NMR spectra recorded at 400 MHz in DMSO-d6, displayed 
characteristic signals which can be, according to their multiplicity, readily assigned to olefinic proton (singlet at 
8.53 ppm) and to aromatic protons (multiplets at 7.68 ppm and 7.58ppm, triplet at 7.2 ppm and doublet at 7 
ppm). Compound 4 was further confirmed by 13C NMR and two-dimensional heteronuclear 1H-13C HSQC and 
HMBC spectroscopy. The signal at d 156.9 ppm corresponded to coumarin carbonyl carbon C-2 and three 
separate signals at δ 141.3, 139.9 and 111.6 ppm corresponded in turn respectively to C-9b, C-3 and C-3a 
(Figure.2).  
 
Figure 3: Synthesis of compounds 4-5 and 8-9 (a) Vilsmeier-Haack conditions: (DMF+POCl3),-10 to -5°C. 
(b)R-NH-NH2.HCl/Et3N, EtOH, 60°C. (c)Piperidine (cat) Pyridine (solvent) 100°C. (d) 1, 2-diaminobenzene, 
Xylene reflux. (e)DMF-DMA, Toluene 100°C. (f) R-NH-NH2.HCl, AcOH reflux. Synthesized compounds are: 
4: 1-phenylchromeno [4, 3-c] pyrazol-4(1H)-one   
5: 1-benzylchromeno [4, 3-c] pyrazol-4(1H)-one  
8: 2-phenylchromeno [4, 3-c] pyrazol-4(1H)-one  
9: 2-benzylchromeno [4, 3-c] pyrazol-4(1H)-one  
3.2. Biological assays 
3.2.1. Anti-proliferative activity analyzed by MTT assay 
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In order to analyze anti-proliferative properties of all the synthesized compounds, we evaluated their 
cytotoxicity with MTT assay. The incubation of Human hepatoma Huh7 cell line with different concentrations 
(0.01µM-100µM) of all coumarinic derivatives was performed up to 48h. Doxorubicin was used as the reference 
drug. Our results showed that all compounds 4, 5, 8 and 9 displayed good cytotoxic effects on Huh7 with half 
maximal inhibitory concentrations (IC50) between 10.37 ± 0.05 µM and 12.94 ± 0.04 µM. These data are shown 
in Table 1. It may be noted that the substituted benzyl ring compounds 5 showed a higher anti-proliferative 
activity (IC50=10.37 ± 0.05 µM) than the other compounds 9 (IC50 = 12.94 ± 0.04 µM), 4 (IC50 = 10.84 ± 0.04 
µM) and 8 (IC50 = 11.02 ± 0.04 µM). 
In addition, the lipophilicity (log P) of the compound may contribute to optimum anti-proliferative activity in as 
much as the higher partition coefficient means that the compound is more likely to penetrate into the membrane 
and bind with intracellular receptor [33]. Actually, according to Table 2, the higher Log P the more the 
compounds were active. 
Table 1 : Anti-proliferative values IC50 (µM) of the 4-Hydroxycoumarin derivatives. Huh7 were treated or not 
with our different compounds at concentrations from 0.01 to 100 µM for 48h. Cell viability was determined by a 
MTT assay and then the IC50 was calculated. The table presents the IC50 of the different compound ± SEM. 
 
Table 2: Log P (lipo-hydro partition coefficient) properties of anti-proliferative agents. 
 
3.2.2. Structural integrity of cell membrane analyzed by LDH assay 
The breakdown of membrane integrity is one of the characteristic features of the process of apoptosis and cell 
a
The log P values were predicted using ChemBioDraw. 
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death. There by the cytotoxicity results in a phase of massive cell lysis. To monitor the evolution of the integrity 
of the cells we measured the release of the enzyme LDH in the supernatant of the cells treated or not by all our 
compounds after 24h, 48h and 72h of incubation (Figure 1). 
 
Figure 1: Effect of compounds 4, 5, 8 and 9 on LDH release induced by Huh7 cells (A, B, C). The addition of 
100 µM, 1 µM and 0.01 µM was during 24h (A), 48h (B) and 72h (C).Results are represented as percent Huh7 
death. 
(A) *P<0.05 versus compounds Dox, 4, 5, 8 and 9, $ P <0.05 versus the concentration of 1µM of all 
compounds,   #P <0.05 versus the concentration of 100 µM of all compounds  
(B) *P<0.05 versus Dox, 4, 5, 8 and 9 except Dox 100 µM, #P ˂0.05 versus the concentration 100 µM of all 
compounds  
(C)*P<0.05 versus Dox, 4, 5, 8 and 9 except Dox 100 µM, $P<0.001 versus 0.01 µM  
#P<0.05 versus the concentration 100 µM of all compounds. 
(D): Effect of compound 5 only on LDH release for 24h, 48h and 72h.*P<0.001 versus control, £ P<0.05 versus 
0.01µM 48h and 0.01µM 72h,# P<0.001 versus 1µM 48 h and 1µM 72h, T P<0.05 versus 0.01µM 72h, 
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µP<0.05 versus 1µM 72h, & P<0.05 versus 100µM 72h. 
The results showed that the LDH activity of each compound was statistically different from that of the control 
group. Thus, we note a significant liberation of LDH into the cell supernatant for the first 24h (Figure 1a) which 
increased significantly with the extension of time, indicating that the different derivatives had both time 
dependent effects which cause cell membrane damage (Figure 1 a-c). The maximum release of LDH was thus 
obtained after 72h of incubation with cytotoxicity higher than 65% for all the compounds. Under basal 
conditions, the LDH is already present in the cytoplasm. 
However, if the cell membrane is damaged, it will leak out of the cell. Therefore, the amount of LDH measured 
in a conditioned media can indirectly give an idea of the degree of damage of the cell membrane integrity. 
Furthermore, the compound 5 remains the most effective with a percentage of cytotoxicity of 50.64% (24h), 65. 
26% (48h), 66.14% (72h) at the concentration of 0.01 μM whereas for that of 1μM the percentages are 58.17% 
(24h), 71.94% (48h),78.63% (72h) and finally the percentages are 65.53% (24h), 84.85% (48h), 85.32% (72h)  
for the  concentration of 100μM. 
3.2.3. Cell spreading assay 
Cell spreading take part in cell movement and progression processes since before migration the cell must adhere 
well and spread to the surface [19, 20], During spreading, the cells undergo morphological changes involving 
the extension of lamellipodia along the extracellular matrix, formation of focal adhesion complexes, 
translocation of the cell body, and posterior detachment from the extracellular matrix. 
Meanwhile, the cells drastically reorganize their cytoskeleton during this extremely dynamic process. The main 
visible feature is the increase of the surface area of contact between the cells and the extracellular matrix, which 
is accompanied by a significant flattening of the cell body and an increase in the total cell area [26]. 
Thus, it was interesting to measure the effectiveness of synthesized HCDs on the spreading of Huh7 liver cancer 
cells, which is a relevant step in tumor progression. Cell morphology was studied after 3h-incubation of Huh7 
cells in the presence or absence of HCD by analysis of red labeling actin, a major cytoskeletal protein. 
After 3h of cell culture with compounds 4, 5, 8 and 9. The results showed that the morphology of the cells 
cultured in the presence of HCD did not have the same morphology as those cultured in its absence and this 
depends on the concentration of HCD (0.01μM, 1μM and 100μM). 
The results obtained using fluorescent microscopy showed that the red labeled cytoskeleton in the cells pass 
from a spherical to a star-shaped form in the presence of all derivatives. The qualitative analysis of the 
morphology of the cells carried out by fluorescence microscopy was confirmed quantitatively by image analysis 
with Scion Image software and expressed in square inch. 
The cell areas were calculated in absence and in the presence of HCD at increasing concentrations (0.01 μM, 1 
μM or 100 μM). We consider a cell spread out as round and with a higher contrast. The areas representing 
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aggregates or clusters of cells were excluded from the data set based on the evaluation of nuclear DAPI 
fluorescence, so that all tagged data were derived from individual cells. The percentage of inhibition of cell 
spreading was determined relative to the control group. All results are presented in the Figure 2. 
 
Figure 2: HCD inhibition of Huh7 cell spreading. In adequate time (3h) and for adequate concentration 
(0.01µM, 1µM and 100µM) 3000 cells/well were plated in glass LabTek, washed with PBS and fixed with 1% 
PFA.  Huh7 were then stained with Phalloidin (F-actin: red) and DAPI (Nucleus: blue), then were imaged with 
fluorescence microscope. Cell spreading was quantified using Scion image software. High resolution zoom 
images of F-actin distribution in Huh7 cells. White scale bar = 20 𝜇𝜇m.
*
P<0.0001 as compared to untreated 
control cells. 
In the absence of HCD, the cells spread out and the large spreading areas were observed, whereas in their 
presence the cell spreading areas were significantly decreased. As shown in Figure 2-B, Huh7 spreading was 
significantly decreased by 55% when the cells were incubated with 1 μM of compound 5 as compared with 
untreated cells (P<0.005, n=3). Meanwhile, the other compounds 4, 8 and 9 had less decreasing effect on Huh7 
spreading by 53%, 51 % and 45 %, respectively, in the same experimental conditions (Figure 2A, C and D).   
3.2.4. Cell invasion assay 
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The four compounds (4, 5, 8 and 9) were studied in an in vitro model of tumor invasion in modified Boyden 
chambers. This model makes it possible to evaluate the capacity of Huh7 cancer cells to pass through a filter 
covered with Matrigel, a biological element of extracellular matrix (ECM), in the presence of a chemotactic 
cytokine Regulated upon Activation, Normal T cell Expressed, and Secreted (RANTES/CCL5). The results 
showed that all coumarin derivatives inhibited to some extent the basal invasion of Huh7 cells through the 
Matrigel. Only for Doxorubicin there was a significant and high inhibition of Huh7 invasion by 60±3 % in basal 
condition. RANTES/CCL5 was then used to stimulate chemotactic Huh7 invasion. The results indicated a 
significant increase in cell invasion by 41±2% in control condition. Interestingly, there was a significant 
decrease of RANTES/CCL5-induced invasion after Doxorubicin, 5 and 8 treatments, by 30%, 34% and 24%, 
respectively.  
 
Figure 3: Invasiveness of Huh7 in presence of 4-hydroxycoumarin derivatives. Huh7 cell invasion was 
performed for 24h in presence of 1 µM of compounds Dox, 4, 5, 8 and 9 and was chemoattracted by 
RANTES/CCL5 (+RANTES/CCL5) or not (- RANTES/CCL5). Results are indicated as cell number/field. 
*P < 0.05 versus control – RANTES/CCL5, $P < 0.05 versus control - RANTES/CCL5, # P < 0.05 versus 
induction by RANTES/CCL5 for control, n=3. 
3.2.5. Cell cycle analyzed by flow cytometry 
The cytostatic effect of the HCD compounds on the Huh7 was evaluated in order to confirm the inhibition of 
cell growth. Huh7 cells were treated with different HCDs at a concentration of 1 μM or 10 μM, then the cell 
were stained with propidium iodide and were analyzed by flow cytometer which detects early changes in 
apoptosis and provides a lucid picture on the nature of cell cycle progression. The cell cycle distribution was 
examined at various times and doses. The results indicate the percentage of living cells in sub-G1, G0/G1 and 
S/G2/M at a concentration of 1 or 10μM. Our results showed that there was a significant increase of Huh7 cells 
at the sub-G1 position (Table 3) after compounds 5 (54.64±17.29%) and 9 (54.41±10.35%) treatments at 10 μM, 
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as compared to control untreated cells (27.92±11.38%). In addition, standard Doxorubicin (Dox) treatment led 
to significant increase of Huh7 cells at the sub-G1 position at 1 µM (67.42±6.21) and at 10 µM (59.42±7.46). In 
parallel we observe a significant decrease of cells in phase S and G2/M only for the Doxorubicin treatment for 
1µM (11.13±4.42%) and for 10 µM (15.63±3.91%) when compared to control untreated cells.  
Table 3: Effect of coumarinic derivatives products on Huh7 cell cycle progression. Huh7 were serum deprived 
for one night and treated or not with coumarinic derivatives or Doxorubicin for 24h at 1 or 10µM. Then, cells 
were stained with propidium iodide-PBS and analysis by flow cytometry. Cell histogram on FL2 was divided 
into three parts according to the cell cycle phases, sub-G1, G0-G1 and S+G2-M. Data are presented with the mean 
± SEM of three independent experiments. *p<0.05 versus untreated cells. 
 
4. Discussion 
A new versatile synthetic route to a new derivatives from N-substituted-4-Oxo-[1] benzopyrano [4, 3-c] 
pyrazole (4, 5, 8 and 9) by the treatment of 4-hydroxycoumarin with different reagents is described; the method 
is rapid and produced all compounds in good yields. The newly synthesized compounds were evaluated for their 
antitumoral activity against Huh7 cells. This series of derivatives were widely active in almost all bioassays. 
With regard to the Anti-proliferative activity analyzed by MTT assay all the title compounds are potent 
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inhibitors and the compound 5 exhibited the most potent inhibitory activity (IC50=10.37µM) against Huh7 cells. 
The cytotoxicity effect was dose-dependent and time-dependent. Indeed all compounds did affect significantly 
Huh7 spreading as compared to untreated control cells even at low concentrations (0.01 μM to 100 μM). The 
ability of derivatives (4, 5, 8 and 9) to inhibit cell spreading was concentration dependent. These results showed 
that the presence of each compound decrease cellular spreading and thus inhibited adhesion of Huh7 cancer 
cells in vitro and that their action was dependent on their concentration, confirming to some extent the results 
obtained by LDH assays. The mechanism of inhibition of cell spreading remains unknown, but we can suppose 
that down-regulation of cell spreading by our compounds may involve effects on cytoskeletal processes required 
for cell spreading in as much as the observed impairment of the actin network forming the peripheral 
cytoskeleton of the cell is involved in both membrane integrity and integrin-mediated cell spreading. All of the 
derivatives (4, 5, 8 and 9) used in this study may thus function as tumor suppressors by causing the embrittlment 
of the membrane and by negatively regulating cell interactions with the extracellular matrix. For example, the 
compound 5 prevented cells from spreading at normal rates, and it reduced to about 38% the number of spread 
cells, at a concentration of 100 μM, with altered morphology and impaired cytoskeletal formation. Also the cell 
viability of Huh7 cells treated with these derivatives and especially with the compound 9 was potentially 
reduced by 81.41 % in the G2 / M phase. So, the presence of apoptotic cells results in an increasing percentage 
at the sub-G1 position [22]. These results suggest that the cell cycle is stopped after treatment, and it may also 
confirm the induction of apoptosis in Huh7 cells by compounds 4, 5, 8 and 9 in a dose dependent manner. 
On the other hand, all derivatives inhibited to some extent the basal invasion of Huh7 cells through the Matrigel 
.This effect may involve actually either inhibition of the spreading of Huh7 cells to the Matrigel and therefore 
their interaction with the components of the MEC. 
Together, these results of the current study should be further confirmed by evaluating anti-cancer activity in vivo 
and may open new avenues for cancer treatment, leading to possible clinical applications. 
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